Biofrontera (BFRI) Change in Receivables (2020 - 2025)

Biofrontera's Change in Receivables history runs 6 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Change in Receivables rose 768.29% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $1.9 million (up 505.4% YoY), while the FY2025 annual figure was $1.9 million, up 505.4% from the prior year.
• Change in Receivables was $4.3 million for Q4 2025 at Biofrontera, up from -$947000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $4.3 million in Q4 2025 to a low of -$3.1 million in Q2 2022.
• Historically, Change in Receivables has averaged $222000.0 across 5 years, with a median of $149500.0 in 2021.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables plunged 30900.0% in 2022, then soared 768.29% in 2025.
• A 5-year view of Change in Receivables shows it stood at $1.8 million in 2021, then grew by 19.7% to $2.2 million in 2022, then plunged by 38.93% to $1.3 million in 2023, then plunged by 63.06% to $492000.0 in 2024, then surged by 768.29% to $4.3 million in 2025.
• The last three Change in Receivables figures came in at $4.3 million (Q4 2025), -$947000.0 (Q3 2025), and -$88000.0 (Q2 2025), per Business Quant data.